(0.31%) 5 107.50 points
(0.67%) 38 641 points
(0.62%) 17 760 points
(0.25%) $79.15
(0.25%) $2.04
(0.02%) $2 310.10
(-0.15%) $26.79
(1.45%) $976.60
(-0.14%) $0.931
(-0.46%) $10.94
(-0.19%) $0.796
(0.55%) $91.63
6.45% $ 2.31
@ $3.23
Emitido: 9 feb 2024 @ 14:14
Retorno: -28.37%
Señal anterior: feb 8 - 10:29
Señal anterior:
Retorno: 1.20 %
Live Chart Being Loaded With Signals
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia...
Stats | |
---|---|
Volumen de hoy | 88 130.00 |
Volumen promedio | 253 221 |
Capitalización de mercado | 60.98M |
EPS | $-0.255 ( 2024-04-01 ) |
Próxima fecha de ganancias | ( $-0.230 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.60 |
ATR14 | $0.0140 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-11 | Hsu Jason | Buy | 31 000 | Common Stock |
2023-12-08 | Hsu Jason | Buy | 25 000 | Common Stock |
2023-08-14 | Morris Gabriel S | Buy | 293 000 | Stock Options |
2023-08-14 | Rachman Ilya M | Buy | 293 000 | Stock Options |
2023-09-15 | Hsu Jason | Buy | 7 000 | Common Stock |
INSIDER POWER |
---|
99.99 |
Last 65 transactions |
Buy: 7 237 723 | Sell: 879 400 |
Volumen Correlación
Immix Biopharma, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
MOMO | 0.931 |
NYMTP | 0.93 |
TOUR | 0.928 |
QFIN | 0.924 |
WB | 0.921 |
OM | 0.917 |
MLCO | 0.917 |
GGAL | 0.917 |
VBNK | 0.915 |
TELA | 0.91 |
10 Correlaciones Más Negativas | |
---|---|
SWAV | -0.921 |
NVTSW | -0.914 |
USCB | -0.913 |
THTX | -0.904 |
LARK | -0.903 |
PCRX | -0.899 |
SNPX | -0.894 |
PIII | -0.894 |
GOSS | -0.894 |
BCAB | -0.892 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Immix Biopharma, Inc. Correlación - Moneda/Commodity
Immix Biopharma, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-5 468.00 (0.00 %) |
EPS: | $-0.890 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-5 468.00 (0.00 %) |
EPS: | $-0.890 |
FY | 2022 |
Ingresos: | $-89.52M |
Beneficio Bruto: | $-89.52M (100.00 %) |
EPS: | $-0.620 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-2 907.85 |
Financial Reports:
No articles found.
Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico